146 related articles for article (PubMed ID: 22982189)
1. Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer.
Wu DW; Tsai LH; Chen PM; Lee MC; Wang L; Chen CY; Cheng YW; Lee H
Am J Pathol; 2012 Nov; 181(5):1796-806. PubMed ID: 22982189
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis.
Chen PM; Cheng YW; Wang YC; Wu TC; Chen CY; Lee H
Neoplasia; 2014 Nov; 16(11):961-71. PubMed ID: 25425970
[TBL] [Abstract][Full Text] [Related]
3. Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer.
Hsu NY; Cheng YW; Chan IP; Ho HC; Chen CY; Hsu CP; Lin MH; Chou MC
Oncol Rep; 2009 Jan; 21(1):81-7. PubMed ID: 19082446
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of interleukin-17 expression by human papillomavirus type 16 E6 in nonsmall cell lung cancer.
Chang YH; Yu CW; Lai LC; Tsao CH; Ho KT; Yang SC; Lee H; Cheng YW; Wu TC; Shiau MY
Cancer; 2010 Oct; 116(20):4800-9. PubMed ID: 20578176
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer.
Cheng YW; Lee H; Shiau MY; Wu TC; Huang TT; Chang YH
Clin Cancer Res; 2008 Aug; 14(15):4705-12. PubMed ID: 18676738
[TBL] [Abstract][Full Text] [Related]
6. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
[TBL] [Abstract][Full Text] [Related]
7. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis.
Cheng YW; Wu TC; Chen CY; Chou MC; Ko JL; Lee H
Clin Cancer Res; 2008 Nov; 14(22):7173-9. PubMed ID: 19010833
[TBL] [Abstract][Full Text] [Related]
8. IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation.
Yun J; Park MH; Son DJ; Nam KT; Moon DB; Ju JH; Hwang OK; Choi JS; Kim TH; Jung YS; Hwang DY; Han SB; Yoon DY; Hong JT
Cell Death Dis; 2018 Feb; 9(3):306. PubMed ID: 29467412
[TBL] [Abstract][Full Text] [Related]
9. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
10. Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer.
Wu DW; Liu WS; Wang J; Chen CY; Cheng YW; Lee H
Clin Cancer Res; 2011 Apr; 17(7):1895-905. PubMed ID: 21325288
[TBL] [Abstract][Full Text] [Related]
11. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
[TBL] [Abstract][Full Text] [Related]
12. cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancer.
Wu HH; Wu JY; Cheng YW; Chen CY; Lee MC; Goan YG; Lee H
Clin Cancer Res; 2010 Nov; 16(21):5200-10. PubMed ID: 20959404
[TBL] [Abstract][Full Text] [Related]
13. Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China.
Fei Y; Yang J; Hsieh WC; Wu JY; Wu TC; Goan YG; Lee H; Cheng YW
Jpn J Clin Oncol; 2006 May; 36(5):274-9. PubMed ID: 16690730
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y
Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747
[TBL] [Abstract][Full Text] [Related]
15. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
[TBL] [Abstract][Full Text] [Related]
16. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1α and VEGF expression in non-small cell lung cancer cells.
Li G; He L; Zhang E; Shi J; Zhang Q; Le AD; Zhou K; Tang X
Cancer Lett; 2011 Dec; 311(2):160-70. PubMed ID: 21868151
[TBL] [Abstract][Full Text] [Related]
18. Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non-small cell lung cancer.
Tung MC; Wu HH; Cheng YW; Wang L; Chen CY; Yeh SD; Wu TC; Lee H
Cancer; 2013 Sep; 119(18):3367-76. PubMed ID: 23797467
[TBL] [Abstract][Full Text] [Related]
19. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
20. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]